5-Amino-1MQ compound UK, supplied in 10mg and 50mg strengths. A small-molecule NNMT inhibitor manufactured to high purity and independently batch tested. For laboratory research use only.
5-Amino-1MQ compound UK is Crown Peptides’ small-molecule NNMT research compound, available in 10mg and 50mg strengths for laboratory research.
5-Amino-1MQ is a quinolinium-based small molecule studied primarily as an inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT participates in nicotinamide metabolism and methyl-donor balance, which has made 5-Amino-1MQ useful in experimental work examining how altered NNMT activity can influence cellular metabolism. Unlike most of the Crown Peptides range, it’s a small molecule rather than a peptide — but it’s studied through the same rigorous laboratory research lens.
Laboratory research involving 5-Amino-1MQ has focused on selective NNMT inhibition and its effect on diet-induced obesity in mouse models (Learn more), and the downstream metabolic consequences of changing nicotinamide methylation, alongside related work on other longevity and metabolic compounds such as [NAD+]. Experimental models have explored adipocyte biology, cellular energy handling, NAD-related pathways and methyl-donor metabolism.
Research context: the 5-Amino-1MQ research areas described above reflect laboratory, preclinical or published scientific investigation. They should not be interpreted as established therapeutic effects, medical claims or approved human uses.
Crown Peptides 5-Amino-1MQ is supplied with batch-specific quality documentation appropriate to the material. Analytical methods vary by compound and formulation, so the Certificate of Analysis should be used as the definitive source for identity, assay, purity and relevant impurity information.
What is 5-Amino-1MQ?
5-Amino-1MQ is a small-molecule research compound studied for its ability to inhibit nicotinamide N-methyltransferase, commonly abbreviated NNMT. Crown Peptides supplies it in 10mg and 50mg strengths.
Why is NNMT important in 5-Amino-1MQ research?
NNMT catalyses the methylation of nicotinamide. Researchers study the enzyme because changes in its activity can influence nicotinamide handling, methyl-donor balance and wider metabolic pathways.
Is 5-Amino-1MQ a peptide?
No. Despite often appearing alongside peptide research products, 5-Amino-1MQ is a small-molecule quinolinium compound rather than a peptide.
What research areas are associated with 5-Amino-1MQ?
Published experimental work has included NNMT activity, adipocyte biology, cellular metabolism, NAD-related pathways and methyl-donor metabolism.
How is 5-Amino-1MQ quality assessed?
The appropriate analytical methods depend on the exact chemical form. Researchers should use the batch-specific Certificate of Analysis as the definitive source for identity, assay and purity information.
Researchers working with 5-Amino-1MQ may also be interested in [NAD+], [MOTS-C], [SS-31], [Epitalon] and [L-Carnitine] — other compounds studied in cellular metabolism, energy balance and longevity-related research.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.